看來載入頁面時發生了錯誤.
我們的團隊已收到通知，但若此問題持續，請透過電郵支援widget工具聯絡我們。
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM Pb Multiple | 1.8x - 2.0x | 1.9x |
| Historical Pb Multiple | 0.6x - 1.9x | 1.2x |
| Fair Value | $8.38 - $9.26 | $8.82 |
| Upside | -14.6% - -5.7% | -10.1% |
| Benchmarks | - | Full Ticker |
| AtriCure, Inc. | - | NasdaqGM:ATRC |
| Boston Scientific Corporation | - | NYSE:BSX |
| Integra LifeSciences Holdings Corporation | - | NasdaqGS:IART |
| ICU Medical, Inc. | - | NasdaqGS:ICUI |
| Penumbra, Inc. | - | NYSE:PEN |
| AngioDynamics, Inc. | - | NasdaqGS:ANGO |
| Select Price / Book Ratio | ||||||||
| Benchmark Companies | ||||||||
| ATRC | BSX | IART | ICUI | PEN | ANGO | |||
| NasdaqGM:ATRC | NYSE:BSX | NasdaqGS:IART | NasdaqGS:ICUI | NYSE:PEN | NasdaqGS:ANGO | |||
| Historical Net Income Growth | ||||||||
| 5Y CAGR | NM- | -17.0% | NM- | NM- | -22.0% | NM- | ||
| 3Y CAGR | NM- | 23.4% | NM- | NM- | 38.4% | NM- | ||
| Latest Twelve Months | -46.8% | 18.0% | -110.3% | -296.9% | -84.6% | 78.5% | ||
| Historical Net Income Profit Margin | ||||||||
| 5 Year Average Margin | -8.2% | 12.3% | 7.2% | 1.7% | 1.5% | -32.7% | ||
| Prior Fiscal Year | -7.6% | 11.0% | 4.4% | -1.3% | 8.6% | -15.5% | ||
| Latest Fiscal Year | -9.6% | 11.1% | -0.4% | -4.9% | 1.2% | -60.7% | ||
| Latest Twelve Months | -9.6% | 11.1% | -0.4% | -4.9% | 1.2% | -14.6% | ||
| Return on Equity | ||||||||
| 5 Year Average Margin | -6.5% | 9.7% | 6.9% | 1.2% | 1.8% | -25.3% | ||
| Prior Fiscal Year | -6.6% | 8.5% | 4.0% | -1.4% | 8.4% | -13.1% | ||
| Latest Twelve Months | -9.6% | 9.0% | -0.4% | -5.8% | 1.2% | -20.5% | ||
| Next Fiscal Year | -6.3% | 17.8% | 11.7% | 8.4% | 12.2% | -6.8% | ||
| Two Fiscal Years Forward | -4.7% | 17.0% | 11.8% | 9.6% | 15.6% | -4.6% | ||
| Current Trading Multiples | ||||||||
| Price / LTM Sales | 3.5x | 8.7x | 1.0x | 1.5x | 8.8x | 1.4x | ||
| Price / LTM EPS | -36.0x | 78.6x | -223.2x | -29.5x | 751.1x | -9.6x | ||
| Price / Book | 3.5x | 6.7x | 1.0x | 1.8x | 9.1x | 2.1x | ||
| Price / Fwd Book | 3.8x | 5.6x | 0.9x | 1.6x | 8.8x | 2.1x | ||
| Low | Mid | High | ||||||
| Benchmark P/B Ratio | 1.0x | 3.5x | 9.1x | |||||
| Historical P/B Ratio | 0.6x | 1.2x | 1.9x | |||||
| Selected P/B Multiple | 1.8x | 1.9x | 2.0x | |||||
| (x) Book Value | 186 | 186 | 186 | |||||
| Equity Value | |||||||
| Benchmark Companies | |||||||
| (in millions) | ATRC | BSX | IART | ICUI | PEN | ANGO | |
| Value of Common Equity | 1,609 | 145,688 | 1,549 | 3,471 | 10,524 | 399 | |
| (/) Shares Outstanding | 48.9 | 1,479.1 | 77.2 | 24.5 | 38.5 | 40.6 | |
| Implied Stock Price | 32.92 | 98.50 | 20.06 | 141.57 | 273.24 | 9.82 | |
| FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |
| Implied Stock Price (Trading Cur) | 32.92 | 98.50 | 20.06 | 141.57 | 273.24 | 9.82 | |
| Trading Currency | USD | USD | USD | USD | USD | USD | |
| FX Rate to Reporting Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |